tradingkey.logo
tradingkey.logo
Search

BREZTRI Met Primary Endpoints In KALOS And LOGOS Phase III Trials In Asthma

ReutersMay 2, 2025 11:14 AM
facebooktwitterlinkedin
View all comments0

- AstraZeneca PLC AZN.L:

  • BREZTRI MET PRIMARY ENDPOINTS IN KALOS AND LOGOS PHASE III TRIALS IN ASTHMA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI